Pre-order Enquiry
Request Free Sample
Global and Japan Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2027
SKU ID : QYR-18960232 | Publishing Date : 23-Aug-2021 | No. of pages : 142
Detailed TOC of Global and Japan Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2027
1 Study Coverage1.1 Measles, Mumps and Rubella (MMR) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Market by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2016-2027
2.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2016-2027
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Measles, Mumps and Rubella (MMR) Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2022-2027)
3 Global Measles, Mumps and Rubella (MMR) Vaccines Competitor Landscape by Players
3.1 Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Sales
3.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Revenue
3.2.1 Key Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2020
3.2.6 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturers
3.4 Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type (2016-2021)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2016-2021)
4.1.3 Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application (2016-2021)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2016-2021)
5.1.3 Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2016-2021)
5.2 Measles, Mumps and Rubella (MMR) Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
6.1.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales YoY Growth 2016-2027
6.1.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue YoY Growth 2016-2027
6.1.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Share in Global Market 2016-2027
6.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Measles, Mumps and Rubella (MMR) Vaccines Players by Sales (2016-2021)
6.2.2 Japan Top Measles, Mumps and Rubella (MMR) Vaccines Players by Revenue (2016-2021)
6.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Type (2016-2021)
6.3.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
6.3.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2016-2021)
6.4 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2022-2027)
6.4.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2022-2027)
6.5 Japan Measles, Mumps and Rubella (MMR) Vaccines Historic Market Review by Application (2016-2021)
6.5.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
6.5.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2016-2021)
6.6 Japan Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2022-2027)
6.6.2 Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 Japan Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
7.2 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
7.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021)
7.2.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
9.2.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021)
9.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
10.2.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Medlmmune
12.1.1 Medlmmune Corporation Information
12.1.2 Medlmmune Description and Business Overview
12.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.1.5 Medlmmune Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Description and Business Overview
12.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.4.5 Sanofi Recent Development
12.5 Serum
12.5.1 Serum Corporation Information
12.5.2 Serum Description and Business Overview
12.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.5.5 Serum Recent Development
12.6 Bavarian Nordic
12.6.1 Bavarian Nordic Corporation Information
12.6.2 Bavarian Nordic Description and Business Overview
12.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.6.5 Bavarian Nordic Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Corporation Information
12.7.2 Astellas Pharma Description and Business Overview
12.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.7.5 Astellas Pharma Recent Development
12.8 Emergent BioSolutions
12.8.1 Emergent BioSolutions Corporation Information
12.8.2 Emergent BioSolutions Description and Business Overview
12.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.8.5 Emergent BioSolutions Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Corporation Information
12.9.2 GlaxoSmithKline Description and Business Overview
12.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Description and Business Overview
12.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.10.5 Pfizer Recent Development
12.11 Medlmmune
12.11.1 Medlmmune Corporation Information
12.11.2 Medlmmune Description and Business Overview
12.11.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Products Offered
12.11.5 Medlmmune Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Trends
13.2 Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
13.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
13.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Measles, Mumps and Rubella (MMR) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2027
List of TablesTable 1. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monovalent Vaccine
Table 3. Major Manufacturers of Polyvalent Vaccine
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions (2016-2021) & (K Doses)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Region (2022-2027) & (K Doses)
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2016-2021) (K Doses)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2020)
Table 20. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Price (2016-2021) (USD/Dose)
Table 21. Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 26. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2016-2021)
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2016-2021)
Table 29. Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type (2022-2027) & (K Doses)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2016-2021)
Table 39. Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application (2022-2027) & (K Doses)
Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 45. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) of Key Companies (2016-2021)
Table 46. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Company (2016-2021)
Table 47. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Company (2016-2021)
Table 49. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2016-2021)
Table 50. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2016-2021)
Table 51. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2016-2021)
Table 53. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2022-2027)
Table 54. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2022-2027)
Table 55. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2022-2027)
Table 57. Japan Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2022-2027)
Table 58. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2016-2021)
Table 59. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 60. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2016-2021)
Table 62. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2022-2027)
Table 63. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2022-2027)
Table 64. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2022-2027)
Table 66. Japan Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2022-2027)
Table 67. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021) & (K Doses)
Table 68. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2016-2021) & (K Doses)
Table 72. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021) & (K Doses)
Table 76. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021) & (K Doses)
Table 80. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2016-2021) & (K Doses)
Table 84. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2016-2021)
Table 87. Medlmmune Corporation Information
Table 88. Medlmmune Description and Business Overview
Table 89. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 90. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product
Table 91. Medlmmune Recent Development
Table 92. Johnson & Johnson Corporation Information
Table 93. Johnson & Johnson Description and Business Overview
Table 94. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Sanofi Corporation Information
Table 103. Sanofi Description and Business Overview
Table 104. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 105. Sanofi Product
Table 106. Sanofi Recent Development
Table 107. Serum Corporation Information
Table 108. Serum Description and Business Overview
Table 109. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 110. Serum Product
Table 111. Serum Recent Development
Table 112. Bavarian Nordic Corporation Information
Table 113. Bavarian Nordic Description and Business Overview
Table 114. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 115. Bavarian Nordic Product
Table 116. Bavarian Nordic Recent Development
Table 117. Astellas Pharma Corporation Information
Table 118. Astellas Pharma Description and Business Overview
Table 119. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 120. Astellas Pharma Product
Table 121. Astellas Pharma Recent Development
Table 122. Emergent BioSolutions Corporation Information
Table 123. Emergent BioSolutions Description and Business Overview
Table 124. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 125. Emergent BioSolutions Product
Table 126. Emergent BioSolutions Recent Development
Table 127. GlaxoSmithKline Corporation Information
Table 128. GlaxoSmithKline Description and Business Overview
Table 129. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 130. GlaxoSmithKline Product
Table 131. GlaxoSmithKline Recent Development
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Business Overview
Table 134. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 135. Pfizer Product
Table 136. Pfizer Recent Development
Table 137. CSL Corporation Information
Table 138. CSL Description and Business Overview
Table 139. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 140. CSL Product
Table 141. CSL Recent Development
Table 142. Measles, Mumps and Rubella (MMR) Vaccines Market Trends
Table 143. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
Table 144. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
Table 145. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
Table 146. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 147. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Product Picture
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Monovalent Vaccine Product Picture
Figure 4. Polyvalent Vaccine Product Picture
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Immune Center
Figure 7. Vaccine Development Agencies and Organizations
Figure 8. Hospital
Figure 9. Laboratory
Figure 10. Biotechnology and Biopharmaceutical Companies
Figure 11. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2016-2027 (US$ Million)
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2016-2027 (K Doses)
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2016-2021)
Figure 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2020
Figure 18. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2016-2021)
Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2020
Figure 20. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2020
Figure 22. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Figure 24. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type in 2020
Figure 25. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2016-2021)
Figure 26. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type in 2020
Figure 27. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Figure 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2020
Figure 29. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2016-2021)
Figure 30. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application in 2020
Figure 31. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2027 (K Doses)
Figure 32. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Measles, Mumps and Rubella (MMR) Vaccines Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue in Measles, Mumps and Rubella (MMR) Vaccines in 2020
Figure 35. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2016-2021)
Figure 36. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2016-2021)
Figure 38. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 40. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2020
Figure 42. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2020
Figure 43. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 44. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 46. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 48. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2020
Figure 50. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2020
Figure 51. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 52. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 54. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 56. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 58. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 60. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 62. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2020
Figure 64. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2020
Figure 65. China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 66. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 68. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 70. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 72. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 74. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 76. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 78. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 80. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 82. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 84. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 86. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 88. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2020
Figure 90. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2020
Figure 91. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 92. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 94. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 96. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate 2016-2021 (K Doses)
Figure 98. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2020
Figure 101. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 102. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 104. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 106. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Measles, Mumps and Rubella (MMR) Vaccines Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Keyplayers in Global and Japan Measles, Mumps and Rubella (MMR) Vaccines Market Insights, Forecast to 2027
MedlmmuneJohnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Request Sample
Request Discount
